The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival outcomes in plasmacytoid urothelial carcinoma: Results with contemporary systemic therapy.
 
Neda Hashemi-Sadraei
No Relationships to Disclose
 
Carmen M Perrino
No Relationships to Disclose
 
M. Francesca Monn
No Relationships to Disclose
 
Elhaam Bandali
No Relationships to Disclose
 
Liang Cheng
No Relationships to Disclose
 
Muhammad Idrees
No Relationships to Disclose
 
Richard Bihrle
No Relationships to Disclose
 
Michael O. Koch
No Relationships to Disclose
 
John Eble
Stock and Other Ownership Interests - Lilly; Lilly (I)
 
Chia-Sui Kao
No Relationships to Disclose
 
Nabil Adra
Research Funding - Merck (Inst)
 
Roberto Pili
Consulting or Advisory Role - Exelixis; Ipsen; Prometheus
Research Funding - Active Biotech; ARIAD; Millennium; Peregrine Pharmaceuticals; Pfizer; Syndax
 
David A. Grignon
Stock and Other Ownership Interests - Abbvie
 
Hristos Z. Kaimakliotis
No Relationships to Disclose
 
Costantine Albany
Stock and Other Ownership Interests - Advaxis
Honoraria - Sanofi
Consulting or Advisory Role - AstraZeneca/MedImmune; Seagen
Speakers' Bureau - Bayer; Sanofi
Research Funding - Astex Pharmaceuticals (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Sanofi